Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Correction to: P66Shc-Induced MicroRNA-34a Causes Diabetic Endothelial Dysfunction by Downregulating Sirtuin1.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: October 22, 2025
Relationship Between Sarcopenia and Intensive Blood Pressure Control Efficacy and Safety: A Secondary Analysis of SPRINT.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: June 17, 2024
Association of Gait Speed With Cognitive Outcomes in Older Adults With Hypertension: A Secondary SPRINT MIND Analysis.
Journal: Journal of aging and physical activity
Published: May 26, 2024
The Role of Triglyceride-rich Lipoproteins and Their Remnants in Atherosclerotic Cardiovascular Disease.
Journal: European cardiology
Published: March 23, 2023
Correction: Metformin prevents vascular damage in hypertension through the AMPK/ER stress pathway.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: September 30, 2022
Genetic deletion of miR-204 improves glycemic control despite obesity in db/db mice.
Journal: Biochemical and biophysical research communications
Published: August 17, 2020
MicroRNAs and obesity-induced endothelial dysfunction: key paradigms in molecular therapy.
Journal: Cardiovascular diabetology
Published: April 27, 2020
Targeting Autophagy in Obesity-Associated Heart Disease.
Journal: Obesity (Silver Spring, Md.)
Published: December 02, 2018
Metformin prevents vascular damage in hypertension through the AMPK/ER stress pathway.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: September 28, 2018
Last Updated: 09/26/2026